Board of Directors of Medtronic Appoints Andrea J. Goldsmith, Ph.D. as a New Director

VERITAS Vision System Is Introduced by Johnson & Johnson

The company will offer live demos of the new system in a wet lab at the Johnson & Johnson booth (#2813) this weekend at the 2021 American Society of Cataract and Refractive Surgery and American Society of Ophthalmic Administrators Annual Meeting.

GenesisCare Orders 27 Elekta Flexitron Treatment Devices

"GenesisCare continues to demonstrate its commitment to improving patient outcomes worldwide and Elekta is delighted to play a vital partnering role to achieve this mission," said Gustaf Salford, Elekta's President and CEO.

FoodMarble AIRE Shown to Exceed the Performance of ‘Gold Standard’ SIBO Testing in Clinical Trial

SIBO is a very common disorder where there are excessive bacteria present in the small intestine. The true prevalence of SIBO in the general population is largely unknown, with some studies estimating its occurrence in up to 15% of healthy individuals. It is also largely associated with many other common clinical conditions, including irritable bowel syndrome, where 40-80% of IBS patients have SIBO.

Today Medtronic announced that the board of directors has appointed Andra J. Goldsmith, Ph.D. as an indepdent irector effective March 11, 2019.

Dr. Goldsmith is the Stephen Harris professor in the School of Engineering at Stanford University and director of Stanford’s Wireless Systems Laboratory. Her research focuses on state-of-the-art wireless system design and the application of information theory and signal processing to neuroscience. Dr. Goldsmith is a widely published expert on this topic and the recipient of multiple awards and honors for her research, including IEEE Fellow. She co-founded and served as Chief Technology Officer of Plume WiFi (formerly Accelera, Inc.) and Quantenna Communications, Inc., and previously held positions at Maxim Technologies, MemoryLink Corporation, and AT&T Bell Laboratories. Previously, she was an assistant professor of Electrical Engineering at the California Institute of Technology.

“We are delighted to have Dr. Goldsmith join our Board of Directors,” said Omar Ishrak, Medtronic chairman and chief executive officer. “With her expertise in wireless system design and the application of information theory and signal processing to biology and neuroscience, she will be a valued adviser as we work to fulfill our Mission to alleviate pain, restore health and extend life for people around the world.”

Dr. Goldsmith currently serves on the Board of Directors for Crown Castle International Corp. She is also co-principal investigator for the NSF Center for Science of Information and is on the technical advisory boards of Sequans Communications and Cohere Technologies. She is a member of the National Academy of Engineering and the American Academy of Arts and Sciences. She received her B.S., M.S. and Ph.D degrees from the University of California at Berkeley.

About Medtronic

Medtronic plc (, headquartered in Dublin, Ireland, is among the world’s largest medical technology, services and solutions companies – alleviating pain, restoring health and extending life for millions of people around the world. Medtronic employs more than 86,000 people worldwide, serving physicians, hospitals and patients in more than 150 countries. The company is focused on collaborating with stakeholders around the world to take healthcare Further, Together.




Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.